Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Damon Reed, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator - G. Douglas Letson, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Connecticut Childrens Medical Center
Hartford, Connecticut, United States
- Nemours/alfred I. Dupont Hospital for Children, Delaware
Wilmington, Delaware, United States
- University of Florida, Gainesville
Gainesville, Florida, United States
- Nemours Children'S Clinic, Jacksonville
Jacksonville, Florida, United States
- University of Miami, Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- All Children'S Hospital, St. Petersburg
St. Petersburg, Florida, United States
- Montefiore Medical Center, Children'S Hospital at Montefiore
The Bronx, New York, United States
- Primary Children'S Medical Center/utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 4 Mar 2016
- Registered enrollment
- 13
- Registry id
- NCT01683149
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.